At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location
- 9 January 2023
- journal article
- research article
- Published by Elsevier BV in Contraception
- Vol. 120, 109955
- https://doi.org/10.1016/j.contraception.2023.109955
Abstract
No abstract availableKeywords
Funding Information
- Society of Family Planning (SFPRF19-11)
This publication has 10 references indexed in Scilit:
- Mifepristone and Misoprostol for Undesired Pregnancy of Unknown LocationObstetrics & Gynecology, 2022
- Abortion Surveillance — United States, 2019Morbidity and Mortality Weekly Report, 2021
- Efficacy and safety of very early medical termination of pregnancy: a cohort studyBJOG: An International Journal of Obstetrics and Gynaecology, 2017
- Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled TrialReproductive Sciences, 2016
- Termination of pregnancy at very early gestation without visible yolk sac on ultrasoundBMJ Sexual & Reproductive Health, 2014
- Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sacContraception, 2013
- Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcomeFertility and Sterility, 2011
- Ectopic PregnancyThe New England Journal of Medicine, 2009
- Verifying the effectiveness of medical abortion; ultrasound versus hCG testingEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- Mifepristone and misoprostol for early abortion when no gestational sac is presentContraception, 2001